You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Johnson and Johnson
Mallinckrodt
Dow
Express Scripts

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

MINOCYCLINE HYDROCHLORIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Minocycline Hydrochloride, and what generic alternatives are available?

Minocycline Hydrochloride is a drug marketed by Aurobindo Pharma, Impax Labs, Sun Pharm Inds Inc, Torrent, Watson Labs, Watson Labs Teva, Zydus, Alkem Labs Ltd, Aurobindo Pharma Ltd, Barr Labs Inc, Impax Labs Inc, Lupin Ltd, Mylan, Mylan Labs Ltd, Mylan Pharms Inc, Sandoz, Sidmak Labs India, Sun Pharm Inds Ltd, Zydus Pharms, Dr Reddys Labs Ltd, Par Pharm, Sun Pharm Industries, and Triax Pharms. and is included in twenty-six NDAs.

The generic ingredient in MINOCYCLINE HYDROCHLORIDE is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Minocycline Hydrochloride

A generic version of MINOCYCLINE HYDROCHLORIDE was approved as minocycline hydrochloride by WATSON LABS on December 30th, 1991.

  Start Trial

Drug patent expirations by year for MINOCYCLINE HYDROCHLORIDE
Recent Clinical Trials for MINOCYCLINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hotchkiss Brain Institute, University of CalgaryPhase 3
Henry Ford Health SystemN/A
Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da SaudePhase 2

See all MINOCYCLINE HYDROCHLORIDE clinical trials

Pharmacology for MINOCYCLINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for MINOCYCLINE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for MINOCYCLINE HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
SOLODYN TABLET, EXTENDED RELEASE;ORAL minocycline hydrochloride 050808 2010-12-13
SOLODYN TABLET, EXTENDED RELEASE;ORAL minocycline hydrochloride 050808 2010-12-02
SOLODYN TABLET, EXTENDED RELEASE;ORAL minocycline hydrochloride 050808 2010-10-27
SOLODYN TABLET, EXTENDED RELEASE;ORAL minocycline hydrochloride 050808 2009-11-19

US Patents and Regulatory Information for MINOCYCLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 203553-004 Nov 16, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Barr Labs Inc MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 065485-003 Mar 17, 2009 DISCN No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma Ltd MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 202261-007 Jun 13, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm Industries MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET;ORAL 090217-002 Jan 29, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 203443-001 Aug 21, 2019 DISCN No No   Start Trial   Start Trial   Start Trial
Sidmak Labs India MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 204394-001 Dec 30, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Lupin Ltd MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 091424-001 Nov 30, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Moodys
Express Scripts
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.